Five Year Hemgenix® Trial Data Published

CSL Behring has published five years of data from their clinical trial of Hemgenix®, a gene therapy product for the treatment of adults with hemophilia B. Learn more about the results of the study.

Source: National Bleeding Disorders Foundation, NBDF Notes, December 2025